相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Patient-Derived Organoids: The Beginning of a New Era in Ovarian Cancer Disease Modeling and Drug Sensitivity Testing
Iason Psilopatis et al.
BIOMEDICINES (2023)
The Role of Patient-Derived Organoids in Triple-Negative Breast Cancer Drug Screening
Iason Psilopatis et al.
BIOMEDICINES (2023)
Switching the Mode of Cell Death between Apoptosis and Autophagy by Histone Deacetylase 6 Inhibition Levels
An-Min Zhou et al.
CHEMMEDCHEM (2023)
Chrysin Modulates Aberrant Epigenetic Variations and Hampers Migratory Behavior of Human Cervical (HeLa) Cells
Ritu Raina et al.
FRONTIERS IN GENETICS (2022)
Histone Deacetylases and their Inhibitors in Colorectal Cancer Therapy: Current Evidence and Future Considerations
Nikolaos Garmpis et al.
CURRENT MEDICINAL CHEMISTRY (2022)
Histone Deacetylase Inhibitory Activity and Antiproliferative Potential of New [6]-Shogaol Derivatives
Chanokbhorn Phaosiri et al.
MOLECULES (2022)
Histone deacetylase inhibitors inhibit cervical cancer growth through Parkin acetylation-mediated mitophagy
Xin Sun et al.
ACTA PHARMACEUTICA SINICA B (2022)
Synthesis and Anticancer Potential of New Hydroxamic Acid Derivatives as Chemotherapeutic Agents
Isil Nihan Korkmaz et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2022)
Organoids: A New Chapter in Sarcoma Diagnosis and Treatment
Iason Psilopatis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
4SC-202 exerts an anti-tumor effect in cervical cancer by targeting PRLR signaling pathway
Huijuan Zhang et al.
JOURNAL OF MOLECULAR HISTOLOGY (2022)
Clinical Significance of the Histone Deacetylase 2 (HDAC-2) Expression in Human Breast Cancer
Nikolaos Garmpis et al.
JOURNAL OF PERSONALIZED MEDICINE (2022)
Histone Deacetylase Inhibitors: A Promising Therapeutic Alternative for Endometrial Carcinoma
Iason Psilopatis et al.
DISEASE MARKERS (2021)
Vorinostat targets UBE2C to reverse epithelial-mesenchymal transition and control cervical cancer growth through the ubiquitination pathway
Botao Pan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives
Robert Jenke et al.
CANCERS (2021)
Trends of cervical cancer at global, regional, and national level: data from the Global Burden of Disease study 2019
Xingxing Zhang et al.
BMC PUBLIC HEALTH (2021)
Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities
Nikolaos Garmpis et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Fucoidan induces ROS-dependent epigenetic modulation in cervical cancer HeLa cell
Saad Mustafa et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)
Trichostatin A Induces Autophagy in Cervical Cancer Cells by Regulating the PRMT5-STC1-TRPV6-JNK Pathway
Jian-Hao Liu et al.
PHARMACOLOGY (2021)
Vorinostat upregulates MICA via the PI3K/Akt pathway to enhance the ability of natural killer cells to kill tumor cells
Chenglai Xia et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Sirtuin 1 Inhibiting Thiocyanates (S1th)-A New Class of Isotype Selective Inhibitors of NAD+ Dependent Lysine Deacetylases
Nathalie Woessner et al.
FRONTIERS IN ONCOLOGY (2020)
N-(2′-Hydroxyphenyl)-2-Propylpentanamide (HO-AAVPA) Inhibits HDAC1 and Increases the Translocation of HMGB1 Levels in Human Cervical Cancer Cells
Yudibeth Sixto-Lopez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Quercetin modifies 5′CpG promoter methylation and reactivates various tumor suppressor genes by modulating epigenetic marks in human cervical cancer cells
Madhumitha Kedhari Sundaram et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Regulatory mechanisms of fluvastatin and lovastatin for the p21 induction in human cervical cancer HeLa cells
Chi-Kang Lin et al.
PLOS ONE (2019)
Exogenous pyruvate represses histone gene expression and inhibits cancer cell proliferation via the NAMPT-NAD+-SIRT1 pathway
Rui Ma et al.
NUCLEIC ACIDS RESEARCH (2019)
Synergistic anticancer effect of panobinostat and topoisomerase inhibitors through ROS generation and intrinsic apoptotic pathway induction in cervical cancer cells
Lubna Wasim et al.
CELLULAR ONCOLOGY (2018)
Trichostatin A resistance is facilitated by HIF-1 alpha acetylation in HeLa human cervical cancer cells under normoxic conditions
Jae-Wook Lee et al.
ONCOTARGET (2018)
Genistein Induces Alterations of Epigenetic Modulatory Signatures in Human Cervical Cancer Cells
Madhumitha Kedhari Sundaram et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2018)
Molecular Docking and Dynamic Simulation Studies of Terpenoids of I. wightii (Bentham) H. Hara against Acetylcholinesterase and Histone Deacetylase3 Receptors
Madhusudhanan Gogul Ramnath et al.
CURRENT COMPUTER-AIDED DRUG DESIGN (2018)
N-(2´-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells
Arturo Contis-Montes de Oca et al.
Oncotarget (2018)
Co-delivery of Vorinostat and Etoposide Via Disulfide Cross-Linked Biodegradable Polymeric Nanogels: Synthesis, Characterization, Biodegradation, and Anticancer Activity
Parveen Kumar et al.
AAPS PHARMSCITECH (2018)
Histone Deacetylase Inhibitors as Anticancer Drugs
Tomas Eckschlager et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Antitumor platinum(IV) derivatives of carboplatin and the histone deacetylase inhibitor 4-phenylbutyric acid
Awatif Rashed Z. Almotairy et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2017)
Induction of colon and cervical cancer cell death by cinnamic acid derivatives is mediated through the inhibition of Histone Deacetylases (HDAC)
Preethi G. Anantharaju et al.
PLOS ONE (2017)
Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer
Christos Damaskos et al.
ANTICANCER RESEARCH (2017)
Development of Substrate-Derived Sirtuin Inhibitors with Potential Anticancer Activity
Nora Kuhlmann et al.
CHEMMEDCHEM (2017)
HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells
Kwon-Ho Song et al.
CANCER RESEARCH (2017)
HTP Nutraceutical Screening for Histone Deacetylase Inhibitors and Effects of HDACis on Tumor-suppressing miRNAs by Trichostatin A and Grapeseed (Vitis vinifera) in HeLa cells
Elizabeth A. Mazzio et al.
CANCER GENOMICS & PROTEOMICS (2017)
Epigenetic regulation of KLK7 gene expression in pancreatic and cervical cancer cells
Ilangovan Raju et al.
BIOLOGICAL CHEMISTRY (2016)
Panobinostat induces apoptosis via production of reactive oxygen species and synergizes with topoisomerase inhibitors in cervical cancer cells
Lubna Wasim et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Valproic acid inhibits the angiogenic potential of cervical cancer cells via HIF-1α/VEGF signals
Y. Zhao et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2016)
Modulating chromatin structure and DNA accessibility by deacetylase inhibition enhances the anti-cancer activity of silver nanoparticles
Nora Igaz et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2016)
Valproic acid exhibits different cell growth arrest effect in three HPV-positive/negative cervical cancer cells and possibly via inducing Notch1 cleavage and E6 downregulation
Shuyu Feng et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Cytotoxic effects of peanut phenolics possessing histone deacetylase inhibitory activity in breast and cervical cancer cell lines
Somprasong Saenglee et al.
PHARMACOLOGICAL REPORTS (2016)
Trichostatin A Enhances the Apoptotic Potential of Palladium Nanoparticles in Human Cervical Cancer Cells
Xi-Feng Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Histone deacetylase (HDAC)-1,-2,-4 and-6 expression in human pancreatic adenocarcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survival
Constantinos Giaginis et al.
BMC GASTROENTEROLOGY (2015)
L- and D-lactate enhance DNA repair and modulate the resistance of cervical carcinoma cells to anticancer drugs via histone deacetylase inhibition and hydroxycarboxylic acid receptor 1 activation
Waldemar Wagner et al.
CELL COMMUNICATION AND SIGNALING (2015)
Prolonged re-expression of the hypermethylated gene EPB41L3 using artificial transcription factors and epigenetic drugs
Christian Huisman et al.
EPIGENETICS (2015)
(-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells
Munawwar Ali Khan et al.
ONCOLOGY REPORTS (2015)
Expression/localization patterns of sirtuins (SIRT1, SIRT2, and SIRT7) during progression of cervical cancer and effects of sirtuin inhibitors on growth of cervical cancer cells
Sapna Singh et al.
TUMOR BIOLOGY (2015)
Survival of primary, but not of cancer cells after combined Plk1-HDAC inhibition
Lisa Lange et al.
ONCOTARGET (2015)
Histone deacetylase inhibitors in oral squamous cell carcinoma treatment
Jason Tasoulas et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2015)
Synergistic combination of histone deacetylase inhibitor suberoylanilide hydroxamic acid and oncolytic adenovirus ZD55-TRAIL as a therapy against cervical cancer
Xiujun Han et al.
MOLECULAR MEDICINE REPORTS (2015)
Reversal of Resistance towards Cisplatin by Curcumin in Cervical Cancer Cells
Madhumita Roy et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Synthesis, molecular docking and cytotoxicity evaluation of novel 2-(4-amino-benzosulfonyl)-5H-benzo[b]carbazole-6,11-dione derivatives as histone deacetylase (HDAC8) inhibitors
P. Ravichandiran et al.
BIOORGANIC CHEMISTRY (2014)
Suberoylanilide hydroxamic acid-induced HeLa cell death is closely correlated with oxidative stress and thioredoxin 1 levels
Bo Ra You et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Nuclear Matrix Protein SMAR1 Represses c-Fos-mediated HPV18 E6 Transcription through Alteration of Chromatin Histone Deacetylation
Samik Chakraborty et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Dynamic Rearrangement of F-Actin Is Required to Maintain the Antitumor Effect of Trichostatin A
Dong-Hee Yang et al.
PLOS ONE (2014)
Epigenetic Silencing of CXCR4 Promotes Loss of Cell Adhesion in Cervical Cancer
Suresh Singh Yadav et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Histone deacetylase (HDAC) inhibitory and antiproliferative activities of phenolic-rich extracts derived from the rhizome of Hydnophytum formicarum Jack.: sinapinic acid acts as HDAC inhibitor
Thanaset Senawong et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
Microtubule-Associated Histone Deacetylase 6 Supports the Calcium Store Sensor STIM1 in Mediating Malignant Cell Behaviors
Ying-Ting Chen et al.
CANCER RESEARCH (2013)
Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and pancreatic carcinomas
Junwei Li et al.
EMBO MOLECULAR MEDICINE (2013)
Trichostatin A induces apoptotic cell death of HeLa cells in a Bcl-2 and oxidative stress-dependent manner
Bo Ra You et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Suberoyl bishydroxamic acid-induced apoptosis in HeLa cells via ROS-independent, GSH-dependent manner
Bo Ra You et al.
MOLECULAR BIOLOGY REPORTS (2013)
Valproic acid inhibits the growth of HeLa cervical cancer cells via caspase-dependent apoptosis
Bo Ram Han et al.
ONCOLOGY REPORTS (2013)
Targeting of Histone Deacetylases to Reactivate Tumour Suppressor Genes and Its Therapeutic Potential in a Human Cervical Cancer Xenograft Model
Dingqing Feng et al.
PLOS ONE (2013)
Enhanced cytotoxic effects of combined valproic acid and the Aurora kinase inhibitor VE465 on gynecologic cancer cells
Yanfang Li et al.
FRONTIERS IN ONCOLOGY (2013)
Evidence of an Epigenetic Modification in Cell-cycle Arrest Caused by the Use of Ultra-highly-diluted Gonolobus Condurango Extract
Kausik Bishayee et al.
JOURNAL OF PHARMACOPUNCTURE (2013)
Combination of Valproic Acid and ATRA Restores RARβ2 Expression and Induces Differentiation in Cervical Cancer through the PI3K/Akt Pathway
D. Feng et al.
CURRENT MOLECULAR MEDICINE (2012)
Histone deacetylase inhibitor BML-210 induces growth inhibition and apoptosis and regulates HDAC and DAPC complex expression levels in cervical cancer cells
Veronika V. Borutinskaite et al.
MOLECULAR BIOLOGY REPORTS (2012)
Notch1-Mediated Tumor Suppression in Cervical Cancer with the Involvement of SST Signaling and Its Application in Enhanced SSTR-Targeted Therapeutics
Laura G. Franko-Tobin et al.
ONCOLOGIST (2012)
Butyrate Histone Deacetylase Inhibitors
Kosta Steliou et al.
BIORESEARCH OPEN ACCESS (2012)
Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer
K. Ted Thurn et al.
FUTURE ONCOLOGY (2011)
A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results
Jaime Coronel et al.
MEDICAL ONCOLOGY (2011)
Histone deacetylase inhibitor-induced sensitization to TNFα/TRAIL-mediated apoptosis in cervical carcinoma cells is dependent on HPV oncogene expression
Katalin Darvas et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
The effect of combined treatment with cisplatin and histone deacetylase inhibitors on HeLa cells
Ke Long Jin et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2010)
Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor, trichostatin A in cervical cancer cells
Priyanka Sharma et al.
MOLECULAR CANCER (2010)
High-Throughput Screening Compatible Cell-Based Assay for Interrogating Activated Notch Signaling
Michael K. Hancock et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2009)
Combination of Proteasome and HDAC Inhibitors for Uterine Cervical Cancer Treatment
Zhenhua Lin et al.
CLINICAL CANCER RESEARCH (2009)
Panobinostat (LBH589): a potent pan-deacetylase inhibitor with promising activity against hematologic and solid tumors
H. Miles Prince et al.
FUTURE ONCOLOGY (2009)
Identification of LIV1, a Putative Zinc Transporter Gene Responsible for HDACi-Induced Apoptosis, Using a Functional Gene Screen Approach
Xiaoli Ma et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Apicidin down-regulates human papillomavirus type 16 E6 and E7 transcripts and proteins in SiHa cervical cancer cells
Michal W. Luczak et al.
CANCER LETTERS (2008)
Valproic acid inhibits the growth of cervical cancer both in vitro and in vivo
Siraj Sami et al.
JOURNAL OF BIOCHEMISTRY (2008)
Proteomic analysis of cervical cancer cells treated with suberonylanilide hydroxamic acid
Jianxiong He et al.
JOURNAL OF BIOSCIENCES (2008)
Histone deacetylase inhibitor apicidin downregulates DNA methyltransferase 1 expression and induces repressive histone modifications via recruitment of corepressor complex to promoter region in human cervix cancer cells
J. S. You et al.
ONCOGENE (2008)
Radiosensitization by the histone deacetylase inhibitor PCI-24781
Carmen A. Banuelos et al.
CLINICAL CANCER RESEARCH (2007)
Design and synthesis of thiazole-5-hydroxamic acids as novel histone deacetylase inhibitors
Sampath-Kumar Anandan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
The role of histone deacetylases (HDACs) in human cancer
Santiago Ropero et al.
MOLECULAR ONCOLOGY (2007)
Genetic redundancy in human cervical carcinoma cells:: Identification of cells with normal properties
Anastasia Bachmann et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
PKCε is essential for gelsolin expression by histone deacetylase inhibitor apicidin in human cervix cancer cells
Dae-Wook Eun et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
The effects of DNA methylation and histone deacetylase inhibitors on human papillomavirus early gene expression in cervical cancer, an in vitro and clinical study
Erick de la Cruz-Hernandez et al.
VIROLOGY JOURNAL (2007)
Chromatin modifications and their function
Tony Kouzarides
CELL (2007)
Dimethyl sulfoxide to vorinostat: Development of this histone deacetylase inhibitor as an anticancer drug
Paul A. Marks et al.
NATURE BIOTECHNOLOGY (2007)
Up-regulation of HLA class-I antigen expression and antigen-specific CTL response in cervical cancer cells by the demethylating agent hydralazine and the histone deacetylase inhibitor valproic acid
Maria de Lourdes Mora-Garcia et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2006)
Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor
P Wu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study
Alma Chavez-Blanco et al.
MOLECULAR CANCER (2005)
Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells
H Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Promoter hypermethylation of FANCF:: Disruption of Fanconi Anemia-BRCA pathway in cervical cancer
G Narayan et al.
CANCER RESEARCH (2004)
Phenylbutyrate inhibits growth of cervical carcinoma cells independent of HPV type and copy number
P Finzer et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2003)
Solvent mediated interactions in the structure of the nucleosome core particle at 1.9 Å resolution
CA Davey et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Combinatorial control of gene expression by nuclear receptors and coregulators
NJ McKenna et al.
CELL (2002)
Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression
P Finzer et al.
ONCOGENE (2001)
Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells
PA Marks et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
